Severe Fever with Thrombocytopenia Syndrome (SFTS) cases first appeared in April 2020 in China and since then, 37 more cases have occurred in Jiangsu and 23 in Anhui Provinces in […]
On July 20, 2020, the Environmental Protection Agency (EPA) registered a new active ingredient called nootkatone, which repels and kill ticks, mosquitoes, and other pests including bed bugs, and fleas. […]
News from Congressman Chris Smith website: The House of Representatives passed an amendment authored by Rep. Chris Smith (R-NJ) which increases Lyme disease research funding by $4 million, for a […]
Persistent Infection a Religious Belief? Working Group Co-Chair Says – YES! At the meeting itself, Working Group Co-Chair, Dr. David Walker, and Member Eugene Shapiro made and seconded many motions to remove material from the proposed draft report including the two sets of guidelines, shared decision making, access to care, Lyme treatment trials, and cost of Lyme disease.
Update: The Bill and passed amendments such as this one (below) has now moved to the conference committee where the House and Senate will work to decide what language goes into the final product. The LDA provided input into the amendment language and has been working to get Senators to champion the inclusion of this GAO Investigation Amendment into the final bill.
The Lyme Disease Association (LDA) announces the publication of its Spanish LymeR Primer (LP). The English LP has been around for more than two decades with countless numbers distributed throughout the US to the public, schools, government, businesses, and health care providers.
Ahora presentamos a la versión descargable en español del LymeR Primer de LDA.
The Lyme Disease Association held the 20th annual scientific conference, Lyme & Other Tick-Borne Diseases: 20th Annual Scientific Update for Clinicians & Researchers, on September 21 & 22, 2019 in […]
LDA Campaign: Patient Access to Care. Our government denies persistent (chronic) Lyme and refuses to acknowledge and help those patients. LDA requested the public submit comments about the existence and importance of persistent (chronic) Lyme. How it affects their life, family, job, school, and doctors. We are pleased to report this campaign was successful and thanks to the many who took action and responded.
The LDA is compiling a list of articles in the news & journals of possible interest regarding Covid-19 & Lyme disease. Autonomic dysfunction in ‘long COVID’: rationale, physiology and management […]
From LDA President Pat Smith’s Blog: It is with great sadness that we in the Lyme community say goodbye to someone whose life was dedicated to helping others through his work as an oncologist and a researcher, Dr. Neil Spector. Dr. Spector devoted his life to saving the lives of others, first through his work on therapies for cancer patients and from his personal experience with Lyme disease.
LDA Doctor Referral System © Terms & Conditions and Guidelines
Save this Information for Your Records:
About LDA DOCTOR REFERRAL SYSTEM ©
Welcome to the Lyme Disease Association’s LDA Doctor Referral System ©. LDA made updates and enhancements to its prior system and has launched a new site to provide patients with information about doctors, other practitioners, testing labs, and pharmacies that are knowledgeable about chronic Lyme disease and often about many other tick-borne diseases (TBD). Many of the doctors listed are often referred to as Lyme Literate Physicians/Doctors (LLMD). Tens of thousands of patients have successfully used the prior LDA system to locate Lyme and TBD resources.
Terms & Conditions and Guidelines
Because there is a negative political climate surrounding Lyme disease, many LLMDs do not want their names posted outright on the internet. LDA has tried to balance the doctors’ wishes with patients’ need to find a doctor. This new system is a result of that compromise and therefore:
Because of the limited number of physicians treating chronic Lyme disease nationwide, some states, and in some instances, entire regions, may not have any treating physicians who follow flexible treating approaches such as those in the International Lyme & Associated Diseases Society (ILADS) Guidelines, Evidence Assessments and Guideline Recommendations in Lyme Disease: The Clinical Management of Known Tick Bites, Erythema Migrans Rashes and Persistent Disease. In the event that the LDA Doctor Referral System © contains no Lyme or TBD resource listings in a given area, the closest possible option(s) will populate based on the location entered and specaialty/ies selected. The LDA appreciates any changes in provider information that you may find and make us aware of so we can investigate.